InMode (INMD)
(Delayed Data from NSDQ)
$17.14 USD
+0.12 (0.71%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $17.24 +0.10 (0.58%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
INMD 17.14 +0.12(0.71%)
Will INMD be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for INMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INMD
Earnings Preview: InMode (INMD) Q1 Earnings Expected to Decline
InMode (INMD) Ascends But Remains Behind Market: Some Facts to Note
INMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is InMode (INMD) a Buy as Wall Street Analysts Look Optimistic?
InMode Ltd. (INMD) is Attracting Investor Attention: Here is What You Should Know
Why InMode (INMD) Outpaced the Stock Market Today
Other News for INMD
Commit To Purchase InMode At $10, Earn 11% Using Options
InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL
InMode responds to petition to USPTO filed by BTL Industries
Analysts Are Bullish on Top Healthcare Stocks: InMode (INMD), Resmed (RMD)
3 Best Stocks to Buy Now, 4/12/2024, According to Top Analysts